Is NCT06694441 recruiting in Chicago, IL?

Yes, NCT06694441 is currently recruiting participants at its Chicago, IL location. This insomnia clinical trial is actively enrolling qualified participants.

How do I join the insomnia clinical trial in Chicago?

To join this clinical trial in Chicago, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Chicago clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Insomnia Clinical Trial in Chicago, IL

About This Insomnia Study in Chicago

This study investigates the relationship between the noradrenergic (NA) system, sleep quality, and cognitive function in older adults with insomnia - a population at elevated risk for Alzheimer's disease-related dementias (ADRD) - compared to age and sex matched controls with normal sleep. The study characterizes NA function through multiple approaches: measuring 24-hour plasma levels of norepinephrine (NE) and its brain metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG); evaluating central NA system response using the clonidine suppression test (a presynaptic α2 adrenoreceptor agonist that reduces locus coeruleus NA activity; and employing pupillometry as a non-invasive marker of autonomic function. To explore NA function's mechanistic role in insomnia, the study uses an intervention with bright light exposure to enhance daytime NA activity, with the goal of improving both sleep quality and cognitive performance.

Sponsor: Northwestern University

Who Can Participate

Inclusion Criteria

Age ≥ 55 years;

Independent in activities of daily living and without clinically significant cognitive impairment as determined by a mini-mental status examination (MMSE) score ≥ 26;

Due to the effect of reproductive hormones on autonomic regulation, sleep and cognition, women will be postmenopausal;

time spent in bed not greater than 8.5 hours;

Sedentary, defined as participation in exercise of moderate intensity for less than 30 minutes per day and less than two times per week on a regular basis.

average daily light exposure indicative of indoor environments (from questionnaire). Inclusion criteria for the insomnia group:

Meet criteria for chronic insomnia disorder according to the International Classification of Sleep Disorders (3rd Ed.);

Subjective sleep efficiency less than 85% and/or awakening earlier than desired if before 6 AM for ≥3 nights/week in the previous 4 weeks;

Subjective WASO (sWASO) ≥ 60 minutes for ≥3 nights/week in previous 4 weeks. sWASO will include time spent awake after sleep onset before final awakening + time spent awake in bed attempting to sleep after the final awakening;

global PSQI score greater than 5;

average daily light exposure indicative of indoor environments (from questionnaire). Inclusion criteria for the control group:

No history of chronic or short-term insomnia disorder according to the International Classification of Sleep Disorders (3rd Ed.);

Subjective sleep efficiency greater than 85%;

Subjective mean total sleep time of 6.5 hours to 8 hours;

Habitual bedtime of 9PM-midnight;

PSQI score ≤ 5. Participants in the control group will be matched with the insomnia group on sex and age (±3 years).

Exclusion Criteria

Sleep disorders other than insomnia (restless legs syndrome, parasomnias, REM behavior disorder, circadian rhythm sleep-wake disorder, sleep apnea by STOP questionnaire and apnea hypopnea index (AHI) ≥ 15 by home sleep apnea test;

habitual bedtime before 9pm or morning awakening before 5am;

History of neurological disorders;

History of psychiatric disorders;

A Beck depression inventory ((BDI-II) score greater than 19);

Unstable or serious medical conditions;

Prediabetes and diabetes (HbA1C ≥ 5.7)

Current, or use within the past month, of psychoactive, hypnotic, stimulant or analgesic medications (except occasionally);

Use of medications that interfere with NA system activity including B-blockers, selective serotonin and norepinephrine reuptake inhibitors (SNRIs) and selective norepinephrine-dopamine reuptake inhibitors (NDRIs);

Hormone replacement therapy;

Use of medications that affects pupil diameter and responses to light (i.e. antihistamines, anticholinergics, benzodiazepines, narcotics for pain;

History of visual abnormalities that may interfere with pupillary responses to light exposure such as significant cataracts, narrow-angle glaucoma or blindness;

History of heart conditions (i.e. arrhythmia, coronary artery disease, angina, heart failure);

Shift work or other types of self-imposed irregular sleep schedules;

BMI \> 35 kg/m2;

History of habitual smoking (6 or more cigarettes/week) or caffeine consumption \> 400 mg/day. 17.Use of weight-loss medications

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT06694441) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Insomnia Treatment Options in Chicago, IL

If you're searching for insomnia treatment options in Chicago, IL, this clinical trial (NCT06694441) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced insomnia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all insomnia clinical trials near you to find additional studies recruiting in your area.

Insomnia Clinical Trial in Chicago, IL

Expert Care in Chicago

IRB Approved

No-Cost Care

Apply for This Chicago Location

Why Participate?

Simple Process